{"entity":{"type":"insider","cik":"0001650389","url":"/insider/0001650389","json_url":"/insider/0001650389.json","name":"FORMAN ERIC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":5,"first":"2016-02-04","last":"2022-12-13","span_basis":"filed_date"},"name_variants":[{"name":"FORMAN ERIC","source":"filing","n_filings":5,"first_seen":"2016-02-04","last_seen":"2022-12-13"}],"transactions":[{"id":6544577,"accession":"0001493152-22-035281","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-22-035281","line_url":"/filing/0001493152-22-035281","is_derivative":false,"issuer_cik":"0001335105","issuer_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","issuer_ticker":"LIXT","issuer_name_source":null,"issuer_url":"/issuer/0001335105","owner_cik":"0001650389","owner_name":"FORMAN ERIC","owner_display_name":"FORMAN ERIC","owner_url":"/insider/0001650389","role":"Officer (Vice President and COO)","role_mark":"O","role_mark_label":"Officer (Vice President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16112.0,"shares_display":"16,112","price_per_share":0.6104803872889771,"price_display":"0.61","price_state":"stated","total_value":9836.06,"total_display":"9,836.06","total_whole":"9,836","shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-09","filed_date":"2022-12-13","scope":"insider","n_lines":3},{"id":6246454,"accession":"0001493152-22-033573","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-22-033573","line_url":"/filing/0001493152-22-033573#line-2","is_derivative":false,"issuer_cik":"0001335105","issuer_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","issuer_ticker":"LIXT","issuer_name_source":null,"issuer_url":"/issuer/0001335105","owner_cik":"0001650389","owner_name":"FORMAN ERIC","owner_display_name":"FORMAN ERIC","owner_url":"/insider/0001650389","role":"Officer (Vice President and COO)","role_mark":"O","role_mark_label":"Officer (Vice President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2484.0,"shares_display":"2,484","price_per_share":0.56,"price_display":"0.56","price_state":"stated","total_value":1391.04,"total_display":"1,391.04","total_whole":"1,391","shares_owned_after":102083.0,"shares_owned_after_display":"102,083","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-22","filed_date":"2022-11-23","scope":"insider"},{"id":6246451,"accession":"0001493152-22-033573","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-033573","line_url":"/filing/0001493152-22-033573#line-1","is_derivative":false,"issuer_cik":"0001335105","issuer_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","issuer_ticker":"LIXT","issuer_name_source":null,"issuer_url":"/issuer/0001335105","owner_cik":"0001650389","owner_name":"FORMAN ERIC","owner_display_name":"FORMAN ERIC","owner_url":"/insider/0001650389","role":"Officer (Vice President and COO)","role_mark":"O","role_mark_label":"Officer (Vice President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1457.0,"shares_display":"1,457","price_per_share":0.56,"price_display":"0.56","price_state":"stated","total_value":815.92,"total_display":"815.92","total_whole":"816","shares_owned_after":99599.0,"shares_owned_after_display":"99,599","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-23","scope":"insider"},{"id":6726265,"accession":"0001493152-22-033084","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001493152-22-033084","line_url":"/filing/0001493152-22-033084","is_derivative":false,"issuer_cik":"0001335105","issuer_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","issuer_ticker":"LIXT","issuer_name_source":null,"issuer_url":"/issuer/0001335105","owner_cik":"0001650389","owner_name":"FORMAN ERIC","owner_display_name":"FORMAN ERIC","owner_url":"/insider/0001650389","role":"Officer (Vice President and COO)","role_mark":"O","role_mark_label":"Officer (Vice President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16207.0,"shares_display":"16,207","price_per_share":0.563026143024619,"price_display":"0.56","price_state":"stated","total_value":9124.9647,"total_display":"9,124.96","total_whole":"9,125","shares_owned_after":89583.0,"shares_owned_after_display":"89,583","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-18","filed_date":"2022-11-21","scope":"insider","n_lines":3},{"id":6726254,"accession":"0001493152-22-033084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-033084","line_url":"/filing/0001493152-22-033084#line-1","is_derivative":false,"issuer_cik":"0001335105","issuer_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","issuer_ticker":"LIXT","issuer_name_source":null,"issuer_url":"/issuer/0001335105","owner_cik":"0001650389","owner_name":"FORMAN ERIC","owner_display_name":"FORMAN ERIC","owner_url":"/insider/0001650389","role":"Officer (Vice President and COO)","role_mark":"O","role_mark_label":"Officer (Vice President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President and COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4852.0,"shares_display":"4,852","price_per_share":0.5398,"price_display":"0.54","price_state":"stated","total_value":2619.1096,"total_display":"2,619.11","total_whole":"2,619","shares_owned_after":81935.0,"shares_owned_after_display":"81,935","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-21","scope":"insider"},{"id":3338077,"accession":"0001493152-16-007545","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-16-007545","line_url":"/filing/0001493152-16-007545#line-2","is_derivative":false,"issuer_cik":"0001335105","issuer_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","issuer_ticker":"LIXT.OB","issuer_name_source":null,"issuer_url":"/issuer/0001335105","owner_cik":"0001650389","owner_name":"FORMAN ERIC","owner_display_name":"FORMAN ERIC","owner_url":"/insider/0001650389","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":3000.0,"total_display":"3,000.00","total_whole":"3,000","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-19","filed_date":"2016-02-19","scope":"insider"},{"id":3338068,"accession":"0001493152-16-007545","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-16-007545","line_url":"/filing/0001493152-16-007545#line-1","is_derivative":false,"issuer_cik":"0001335105","issuer_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","issuer_ticker":"LIXT.OB","issuer_name_source":null,"issuer_url":"/issuer/0001335105","owner_cik":"0001650389","owner_name":"FORMAN ERIC","owner_display_name":"FORMAN ERIC","owner_url":"/insider/0001650389","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43500.0,"shares_display":"43,500","price_per_share":0.298,"price_display":"0.30","price_state":"stated","total_value":12963.0,"total_display":"12,963.00","total_whole":"12,963","shares_owned_after":90000.0,"shares_owned_after_display":"90,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-17","filed_date":"2016-02-19","scope":"insider"},{"id":2687176,"accession":"0001493152-16-007181","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-16-007181","line_url":"/filing/0001493152-16-007181#line-2","is_derivative":false,"issuer_cik":"0001335105","issuer_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","issuer_ticker":"LIXT.OB","issuer_name_source":null,"issuer_url":"/issuer/0001335105","owner_cik":"0001650389","owner_name":"FORMAN ERIC","owner_display_name":"FORMAN ERIC","owner_url":"/insider/0001650389","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":625.0,"total_display":"625.00","total_whole":"625","shares_owned_after":46500.0,"shares_owned_after_display":"46,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-04","filed_date":"2016-02-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001335105","name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","url":"/issuer/0001335105","role":"Officer (Vice President and COO), Ten percent owner","n_filings":5,"first_seen":"2016-02-04","last_seen":"2022-12-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001650389","retrieved_at":"2026-08-25T22:09:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}